Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
1325208-25-0
1433997-01-3
1807518-72-4
1807537-42-3
955094-26-5
2055033-05-9
113975-32-9 | N-(4-Iodo-pyridin-3-yl)-2,2-dimethyl-propionamide | AA000A59 | MFCD06659003
1142194-28-2 | 4-Bromo-N,N-diethylpyridin-2-amine | AA000ARP | MFCD11869617
1160246-72-9 | tert-Butyl 2-oxo-1,7-diazaspiro[4.4]nonane-7-carboxylate | AA000BBS | MFCD12198506
116140-49-9 | 3-Methylpiperidine-3-carboxylic acid | AA000BND | MFCD12024776
116371-67-6 | Gemcitabine monophosphate | AA000C8X | MFCD18252926
116632-42-9 | 2-Chloro-1-iodo-4-methylbenzene | AA000CUB | MFCD00079734
116934-87-3 | 4-(Methoxycarbonyl)-3-methylbenzoic acid | AA000DBQ | MFCD17676540
1170936-92-1 | 2-(3-Aminophenyl)pyridine DiHCl | AA000DM4 | MFCD08235170
1172490-52-6 | 5,7-Dichloro-4-hydrazinoquinoline hydrochloride | AA000DWH | MFCD09787762
1174020-30-4 | (3S,4R)-tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate | AA000E5S | MFCD12756143